ADVISORY/Experts Available To Discuss Participation in Cancer Research.Business Editors ADVISORY... --(BUSINESS WIRE) TOPIC: Lance Armstrong, five-time Tour de France Tour de France World's most prestigious and difficult bicycle race. Staged for three weeks each July—usually in some 20 daylong stages—the Tour typically comprises 20 professional teams of nine riders each and covers some 3,600 km (2,235 miles) of flat and winner, is periodically joining in with participants throughout the "Tour of Hope" cycle ride to advocate participation in cancer research, according to an article by SFGate.com. Twenty-six participants, including cancer survivors and doctors, began the 3,200-mile cycle ride last Saturday in Universal City, Calif. The tour is scheduled to end this Saturday in Washington, DC. EXPERTS: ExpertSource can offer several highly qualified experts to comment on this story: Dr. Steven Peskin, CEO of Pharmaceutical Research Plus, a leading clinical trial support company in Baltimore, is available to discuss how we can dispel some of the stigma surrounding clinical trials. Prior to joining PRP, Dr. Peskin was president of Nelson Managed Solutions in Princeton, N.J., a managed care consulting firm and division of Publicis Healthcare Group. Dr. Peskin has held clinical faculty appointments at Tufts-New England Medical Center Tufts-New England Medical Center (Tufts-NEMC) is a medical institution in Boston, Massachusetts. It is a center for research and is the principal teaching hospital for Tufts University School of Medicine where all full-time Tufts-NEMC physicians hold faculty appointments. , University of Texas Southwestern, University of Oklahoma University of Oklahoma, abbreviated OU, is a coeducational public research university located in the U.S. state of Oklahoma. Founded in 1890, it existed in Oklahoma Territory near Indian Territory 17 years before the two became the state of Oklahoma. and currently at the University of Medicine and Dentistry of New Jersey The University of Medicine and Dentistry of New Jersey is the state-run health sciences institution of New Jersey and comprises eight distinct academic units: the New Jersey Medical School, the New Jersey Dental School, the Graduate School of Biomedical Sciences, the School of . He is a Diplomat of the American Board of Internal Medicine The American Board of Internal Medicine (ABIM) is a non-profit, independent physician organization in the U.S. that certifies physicians who practice in internal medicine and its sub-specialties. and a Fellow of the American College of Physicians The American College of Physicians (ACP) is a national organization of doctors of internal medicine (internists), physicians who specialize in the prevention, detection and treatment of illnesses in adults. . PR Contact: Jennifer Heinly 949-716-9829 jjconsultin@cox.net Dr. Joyce O'Shaughnessy is currently a breast cancer researcher and practitioner at Texas Oncology, P.A. in Dallas and is Associate Director for clinical research for US Oncology. She is also Director, Chemoprevention che·mo·pre·ven·tion n. The use of chemical agents, drugs, or food supplements to prevent disease. chemoprevention Research and Co-Director, Breast Cancer Research for US Oncology. Dr. O'Shaughnessy's major area of research interest is the development of breast cancer. She is involved in several ongoing chemoprevention studies. She served as special assistant to the National Cancer Institute's director from 1988 to 1990 and coordinated the development of new cancer drug approval guidelines for the NCI and Food and Drug Administration. Dr. O'Shaughnessy then served as a Senior Investigator in the Medical Breast Cancer Section of the NCI from 1990 through 1995. In this role, she conducted many breast cancer treatment This article or section recently underwent a major revision or rewrite and needs further review. You can help! The mainstay of breast cancer treatment is surgery when the tumor is localized, with possible adjuvant hormonal therapy (with tamoxifen or an aromatase clinical trials, including evaluation of high-dose chemotherapies and hematopoietic hematopoietic /he·ma·to·poi·et·ic/ (-poi-et´ik) 1. pertaining to hematopoiesis. 2. an agent that promotes hematopoiesis. hematopoietic 1. pertaining to or affecting the formation of blood cells. growth factors, new cytotoxic drug combinations, novel hormonal treatments, monoclonal antibody and gene therapies for breast cancer. Dr. O'Shaughnessy also has served as principal investigator on several tissue-based breast cancer prevention clinical trials involving the administration of fenretinide, tamoxifen, and other SERMs to women at high risk for the development of breast cancer. 214-370-1000 joyce.oshaughnessy@usoncology.com Professor Ian Nicholas Crispe, of Yale University, can share his expertise concerning cancer research and immunology. 203-785-7541 203-432-4771 (University PR Phone) Professor Jun Liu, of Massachusetts Institute of Technology Massachusetts Institute of Technology, at Cambridge; coeducational; chartered 1861, opened 1865 in Boston, moved 1916. It has long been recognized as an outstanding technological institute and its Sloan School of Management has notable programs in business, , Center for Cancer Research Departments of Biology and Chemistry, is an expert regarding cancer research, immunology and pharmacology. 617-253-5750 617-253-1000 (University PR Phone) ExpertSource cannot guarantee the immediate availability of these experts or their familiarity with this specific issue. ExpertSource provides academic and industry experts to the media at no charge. Journalists are encouraged to submit queries to ExpertSource when seeking experts on specific subjects. An online registration form is available at http://www.businesswire.com/. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion